Kwangdong Pharmaceutical Co Ltd
KRX:009290
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| KR |
|
Kwangdong Pharmaceutical Co Ltd
KRX:009290
|
373.2B KRW |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
966.3B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
586.6B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
290.5B CHF |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
245.6B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
234.2B GBP |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
298.1B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
154.7B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123B USD |
Loading...
|
Market Distribution
| Min | -646.5% |
| 30th Percentile | 12.8% |
| Median | 19.7% |
| 70th Percentile | 32.2% |
| Max | 54 001.3% |
Other Profitability Ratios
Kwangdong Pharmaceutical Co Ltd
Glance View
Kwang Dong Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Seoul, Seoul. The firm operates its business through five segments. The Mineral Water Business segment supplies drinking spring water under Samdasoo brand. The Distribution Business segment distributes health drinks under brand names of Vita500 and Corn Silk Tea. The Pharmacy Business segment provides Chinese prescription cold medicines, hypertension medicines, cerebral apoplexy medicines and health drinks. The Hospital Business segment offers anticancer agents, blood vessel adjuvants, vitamin D injections and others. The Other segment provides products which not covered by Pharmacy, Hospital and Distribution segments.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Kwangdong Pharmaceutical Co Ltd is 17.9%, which is below its 3-year median of 18.9%.
Over the last 3 years, Kwangdong Pharmaceutical Co Ltd’s Gross Margin has decreased from 19.8% to 17.9%. During this period, it reached a low of 17.5% on Jun 30, 2025 and a high of 20.1% on Jun 30, 2023.
